Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 2,543 | 1,602 | N/A | N/A |
| TOTAL | $3,122 | $2,111 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 1,700 | 2,082 | N/A | N/A |
| Other Non-Current Assets | 238 | 255 | 0 | 0 |
| TOTAL | $1,938 | $2,337 | $N/A | $N/A |
| Total Assets | $5,060 | $4,448 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 548 | 473 | 0 | 0 |
| Accrued Expenses | 666 | 476 | N/A | N/A |
| TOTAL | $1,665 | $1,561 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 113 | 325 | N/A | N/A |
| TOTAL | $131 | $579 | $N/A | $N/A |
| Total Liabilities | $1,796 | $2,140 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -36,557 | -26,113 | N/A | N/A |
| Other shareholders' equity | 38,894 | 27,513 | 0 | 0 |
| TOTAL | $3,264 | $2,308 | $N/A | $N/A |
| Total Liabilities And Equity | $5,060 | $4,448 | $0 | $0 |